Abeona therapeutics® appoints james a. gow, md, mba, ms, mhcm, as senior vice president, head of clinical development & medical affairs

Cleveland, oct. 20, 2025 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the appointment of james a. gow, md, mba, ms, mhcm, as the senior vice president, head of clinical development & medical affairs, effective immediately.
ABEO Ratings Summary
ABEO Quant Ranking